All In MedTech

Device Trial Radar · NCT03080714

Triton Agreement and Precision Study

Topcon DRI OCT Triton Agreement and Precision Study

Last checked: Nov 19, 2026Latest source record: Jun 8, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

88

Actual

Start

Mar 13, 2017

Primary completion

Aug 30, 2017

Study completion Oct 30, 2017

Sponsor

Lead sponsor
Topcon Medical Systems, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Mar 15, 2017

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

To Compare the agreement and precision between the Topcon DRI OCT Triton and the 3D OCT-1 Maestro with RDB.

Conditions

  • Healthy Eyes
  • Eye Diseases

Interventions

  • Topcon DRI OCT Triton (plus)Device

    The Topcon DRI OCT Triton (plus) is an OCT machine used for diagnostic purposes

  • 3D OCT-1 MaestroDevice

    The 3D OCT-1 Maestro is an OCT machine used for diagnostic purposes

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Retinal ThicknessTime frame: 1 Minute

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Fischer Laser Eye Center

    Willmar, Minnesota

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.